Ovarian Cancer News & Features

June 14, 2021 — Christiane Amanpour, the chief international anchor for CNN, announced Monday at the start of her daily TV program that she’s been diagnosed with ovarian cancer.

June 2, 2021 — The U.S. Supreme court said Tuesday that it won't hear Johnson & Johnson's appeal over a $2 billion ruling in favor of women who said they developed ovarian cancer from using the company's talc products.

May 26, 2021 — Here’s what people with ovarian cancer want you to know about this condition.

May 25, 2021 — Learning to live with ovarian cancer can feel overwhelming. But there are ways to ease the transition.

May 18, 2021 — A huge British trial turned out negative: annual screening of healthy women for ovarian cancer did not reduce deaths from this aggressive cancer.

May 17, 2021 — A new blood test claims to find up to 50 different cancers from single blood draw; it may be used to along with other cancer screening tests.

May 14, 2021 — Here’s what two doctors who treat gynecologic cancers want you to know about spotting ovarian cancer as early as possible.

May 12, 2021 — When used under a doctor’s supervision, complementary therapies can make it easier to get through treatment for ovarian cancer. Here’s what you should know.

March 25, 2021 — A recent study suggests that "maintenance therapy" with a targeted cancer drug may add years to some patients' lives.

November 19, 2020 — Previous studies suggested that women who used this assisted reproductive technologies (ART) such as IVF to get pregnant may be at risk for ovarian cancer and non-malignant borderline tumors

April 3, 2020 — Survival of patients with advanced ovarian cancer continues to increase, despite concerns that increased use of neoadjuvant chemotherapy (NAC) could have a negative impact on outcomes.

June 25, 2019 — At only 2 years of age, McKenna Xydias is a cancer survivor.

June 2, 2019 — or the study, the investigators analyzed data from the U.S. National Cancer Database. They compared nearly 36,000 women who were diagnosed and treated between 2004 and 2009, with more than 37,000 women diagnosed and treated between 2011 and 2014.

April 3, 2019 — After adjusting for such factors as age and whether women had ever given birth, any use of birth control pills was associated with a 46% lower risk of death within a year of an ovarian cancer diagnosis, the study found.

February 21, 2019 — Johnson & Johnson is being investigated by the U.S. Justice Department and the U.S. Securities and Exchange Commission over possible asbestos contamination of the company's baby powder and other talc-based products.

October 4, 2018 — Researchers say that women who reported recent, regular use of low-dose aspirin (100 milligrams or less) had a 23 percent lower risk of developing ovarian cancer than those who did not regularly take aspirin.

July 20, 2018 — One low-dose aspirin -- the type many older women already take to help their hearts -- was tied to a 10 percent reduction in developing ovarian cancer and as much as a 30 percent improvement in survival for ovarian cancer patients, two new studies have found.

July 13, 2018 — A jury says Johnson & Johnson must pay $4.62 billion to 22 women who allege they developed ovarian cancer after using the company's Baby Powder and Shower to Shower brand talcum powder as part of their daily feminine hygiene routine.

July 2, 2018 — However, there is a slight risk that the ovarian tissue may contain cancer cells, putting a woman at risk for the return of her cancer.

March 29, 2018 — One study found that a new targeted "immunotherapy" to treat ovarian cancer that has come back looked promising in a small, early trial.

March 21, 2018 — The researchers behind the new study developed a testing regimen called PapSEEK to see if additional samples collected during a pelvic exam could be used to detect endometrial or ovarian cancer.

February 13, 2018 — Screening not only didn’t prevent any deaths, it also led to harm, the panel said.

January 18, 2018 — According to the study from the U.S. National Cancer Institute, these trends were also observed for endometrial cancer as well.

December 18, 2017 — A new ovarian cancer drug niraparib (Zejula) that can prolong survival has been licenced for use in Europe, including the UK.

October 18, 2017 — Award in Missouri case set aside upon appeal. Does not affect larger California award in similar suit.

August 22, 2017 — Verdict was fourth against Johnson & Johnson

December 21, 2016 — Ovarian Cancer Drug Given Fast-Track Approval

November 4, 2016 — Leading cancer and women's health groups say probably not

October 28, 2016 — Woman Gets $70M in Baby Powder/Ovarian Cancer Suit

September 9, 2016 — Because early signs are often easy to ignore, 140,000 women worldwide die of the disease every year

September 9, 2016 — May delay preventive therapies for high-risk women, spur unnecessary procedures in some without cancer

September 7, 2016 — Rates down 16 percent in U.S., 8 percent in Canada, and 10 percent in Europe over a decade: study

June 21, 2016 — Chronic inactivity linked to greater risk for the disease in study

June 4, 2016 — Study found using both abdomen drip and IV delayed progression of disease

June 3, 2016 — Advanced age, disease were predictors for receiving only chemo, radiation or nothing at all

March 2, 2016 — Better understanding needed to improve prevention, detection, treatment, U.S. panel notes

February 24, 2016 — $72M Awarded in Johnson & Johnson Baby Powder Case

December 17, 2015 — Analyzing results over time can detect harmful changes, study suggests

November 3, 2015 — Women who've had their tubes tied also seemed to be protected

September 29, 2015 — Hormone replacement therapy may be safe for women with ovarian cancer, according to a new study published in the Journal of Clinical Oncology.

August 24, 2015 — But researchers say clinical trials needed to prove older beta blockers lengthen life in these patients

August 11, 2015 — Many of these patients even had 'high-risk' disease that lowered odds of a good prognosis

August 5, 2015 — Almost a decade ago, the National Cancer Institute alerted doctors that a treatment that could extend the lives of women with advanced ovarian cancer was not being used often enough.

May 20, 2015 — Shrinking the tumor beforehand seems to raise quality of life without shortening survival, study finds

May 7, 2015 — Women diagnosed today 50 percent less likely to die than they were in the 1970s, researchers say

May 5, 2015 — A screening method that uses blood tests can spot twice as many cases of ovarian cancer as older techniques can, and that may lead to women getting diagnosed sooner, researchers say.

December 19, 2014 — Agency also gives OK to genetic test used to identify eligible patients

October 7, 2014 — Preliminary finding may bring doctors one step closer to test that could catch the disease in early stages

May 31, 2014 — Preliminary findings suggest this experimental treatment might slow disease